Skip to main content
Inari Medical, Inc. (NARI)
NASDAQ: NARI · IEX Real-Time Price · USD
50.00
-0.69 (-1.36%)
May 31, 2024, 4:00 PM EDT - Market closed

Inari Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018
Revenue
493.63383.47276.98139.6751.13
Upgrade
Revenue Growth (YoY)
28.73%38.45%98.31%173.17%648.70%
Upgrade
Cost of Revenue
59.0744.5124.7613.115.91
Upgrade
Gross Profit
434.56338.97252.23126.5645.22
Upgrade
Selling, General & Admin
361.06292.84190.3789.7537.2
Upgrade
Research & Development
87.5374.2251.0218.47.22
Upgrade
Operating Expenses
448.6367.06241.38108.1544.42
Upgrade
Operating Income
-14.03-28.110.8418.420.8
Upgrade
Interest Expense / Income
0.20.290.31.140.92
Upgrade
Other Expense / Income
-18.47-2.21-0.143.51.07
Upgrade
Pretax Income
4.25-26.1910.6913.79-1.19
Upgrade
Income Tax
5.883.080.8500
Upgrade
Net Income
-1.64-29.279.8413.79-1.19
Upgrade
Net Income Growth
---28.64%--
Upgrade
Shares Outstanding (Basic)
575350326
Upgrade
Shares Outstanding (Diluted)
575356526
Upgrade
Shares Change
7.44%-4.96%7.83%775.66%16.43%
Upgrade
EPS (Basic)
-0.03-0.550.200.43-0.20
Upgrade
EPS (Diluted)
-0.03-0.550.180.27-0.20
Upgrade
EPS Growth
---33.33%--
Upgrade
Free Cash Flow
29.73-23.9211.84-3.55-8.08
Upgrade
Free Cash Flow Per Share
0.52-0.450.24-0.11-1.37
Upgrade
Gross Margin
88.03%88.39%91.06%90.62%88.44%
Upgrade
Operating Margin
-2.84%-7.33%3.92%13.19%1.57%
Upgrade
Profit Margin
-0.33%-7.63%3.55%9.87%-2.33%
Upgrade
Free Cash Flow Margin
6.02%-6.24%4.27%-2.54%-15.80%
Upgrade
Effective Tax Rate
138.53%-7.91%--
Upgrade
EBITDA
15.18-18.7715.2916.310.34
Upgrade
EBITDA Margin
3.07%-4.90%5.52%11.68%0.67%
Upgrade
Depreciation & Amortization
10.747.124.311.390.61
Upgrade
EBIT
4.44-25.8910.9814.92-0.27
Upgrade
EBIT Margin
0.90%-6.75%3.96%10.69%-0.53%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).